- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic plaque psoriasis (CPP)
- Meeting Date: November 2019
- Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)
Certolizumab pegol – November 2019
Certolizumab pegol: Injection 200 mg in 1 mL single use pre-filled syringe, Solution for injection 200 mg in 1 mL pre-filled pen; Cimzia®
Last updated
30 May 2025